Sale!

Sphingolipidosis Panel 3 Test Cost

Original price was: 1,300 د.إ.Current price is: 1,170 د.إ.

-10%

The Sphingolipidosis Panel 3 Test is a specialized diagnostic assessment designed to detect a group of inherited metabolic disorders known as sphingolipidoses. These disorders result from the malfunctioning breakdown of sphingolipids, which are essential components of cell membranes. Accumulation of these substances can lead to a variety of health issues, affecting the brain, nervous system, and other organs. The test is particularly crucial for early detection and management of these conditions, which can significantly impact the quality of life.

Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test involves analyzing specific genetic markers associated with sphingolipidoses. This comprehensive approach ensures a high degree of accuracy and provides critical information for treatment planning and genetic counseling.

The cost of the Sphingolipidosis Panel 3 Test is 1170 AED, making it a valuable investment for individuals at risk of these genetic disorders. By choosing DNA Labs UAE for this test, patients benefit from the expertise of a dedicated team of specialists, state-of-the-art technology, and a commitment to providing actionable health insights.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SPHINGOLIPIDOSIS PANEL 3 Test

The Sphingolipidosis Panel 3 test is a diagnostic test used to identify and confirm the presence of certain sphingolipid storage disorders, also known as sphingolipidoses. These disorders are characterized by the abnormal accumulation of sphingolipids in various tissues and organs.

The panel includes the analysis of specific enzymes involved in the breakdown of sphingolipids, such as hexosaminidase A and B, arylsulfatase A, and galactocerebrosidase. Deficiencies in these enzymes can indicate the presence of specific sphingolipidoses, such as Tay-Sachs disease, Sandhoff disease, metachromatic leukodystrophy, and Krabbe disease.

The test is typically performed on a blood or tissue sample, and the levels of these enzymes are measured. Abnormally low enzyme activity levels can suggest the presence of a specific sphingolipid storage disorder. Additional tests, such as genetic testing or further enzyme analysis, may be required to confirm the diagnosis.

The Sphingolipidosis Panel 3 test is useful in the early detection and diagnosis of sphingolipidoses, allowing for timely treatment and management of these rare genetic disorders. It can also be used for carrier testing and genetic counseling for individuals with a family history of sphingolipid storage disorders.

Test Details

  • Test Name: SPHINGOLIPIDOSIS PANEL 3 Test
  • Components: GM 1 Gangliosidosis, Gaucher Disease, Niemann Pick Disease
  • Price: 1170.0 AED
  • Sample Condition: 10 mL (7.5 mL min.) whole blood from 3 Lavender Top (EDTA) / Green Top (Sodium Heparin) tubes. Ship refrigerated within 48 hrs. DO NOT FREEZE. Clinical history must accompany sample.
  • Report Delivery: Sample daily by 4pm; Report 4 days
  • Method: Enzyme assay
  • Test Type: Inborn errors of metabolism
  • Doctor: Pediatrician
  • Test Department: Genetic
  • Pre Test Information: Give brief clinical history.

For more information or to schedule a SPHINGOLIPIDOSIS PANEL 3 test, please contact DNA Labs UAE.

Test Name SPHINGOLIPIDOSIS PANEL 3 Test
Components *GM 1 Gangliosidosis*GaucherDisease *Niemann Pick Disease
Price 1170.0 AED
Sample Condition 10 mL (7.5 mL min.) whole blood from 3LavenderTop(EDTA)\/GreenTop (SodiumHeparin)tubes.Ship refrigeratedwithin48hrs.DONOT FREEZE. Clinical history must accompanysample.
Report Delivery SampleDailyby4pm;Report4days
Method Enzyme assay
Test type Inborn errors of metabolism
Doctor Pediatrician
Test Department: GENETIC
Pre Test Information Give brief clinical history.
Test Details

The Sphingolipidosis Panel 3 test is a diagnostic test used to identify and confirm the presence of certain sphingolipid storage disorders, also known as sphingolipidoses. These disorders are characterized by the abnormal accumulation of sphingolipids in various tissues and organs.

The panel includes the analysis of specific enzymes involved in the breakdown of sphingolipids, such as hexosaminidase A and B, arylsulfatase A, and galactocerebrosidase. Deficiencies in these enzymes can indicate the presence of specific sphingolipidoses, such as Tay-Sachs disease, Sandhoff disease, metachromatic leukodystrophy, and Krabbe disease.

The test is typically performed on a blood or tissue sample, and the levels of these enzymes are measured. Abnormally low enzyme activity levels can suggest the presence of a specific sphingolipid storage disorder. Additional tests, such as genetic testing or further enzyme analysis, may be required to confirm the diagnosis.

The Sphingolipidosis Panel 3 test is useful in the early detection and diagnosis of sphingolipidoses, allowing for timely treatment and management of these rare genetic disorders. It can also be used for carrier testing and genetic counseling for individuals with a family history of sphingolipid storage disorders.